REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Morgan Stanley Upgrades Barclays To Overweight

Tue, 03rd Feb 2015 09:38

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
UBS RAISES SKY PLC PRICE TARGET TO 1200 (1100) PENCE - 'BUY'
----------
BERENBERG CUTS ASHTEAD GROUP PRICE TARGET TO 1295 (1345) PENCE - 'BUY'
----------
CITIGROUP RAISES WOLSELEY PRICE TARGET TO 3900 (3800) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS SHELL A TO 'NEUTRAL' ('OVERWEIGHT') - PRICE TARGET 2100 (2500) PENCE
----------
PANMURE INITIATES MEGGITT WITH 'BUY' - TARGET 698 PENCE
----------
MORGAN STANLEY RAISES BARCLAYS TO 'OVERWEIGHT' ('EQUALWEIGHT') - PRICE TARGET 315 (270) PENCE
----------
FTSE 250
----------
BARCLAYS RAISES BRITVIC TO 'OVERWEIGHT' ('EQUALWEIGHT') - TARGET 800 (725) PENCE
----------
GOLDMAN CUTS NMC HEALTH TO 'NEUTRAL' ('BUY') - TARGET 575 (578) PENCE
----------
GOLDMAN RAISES AL NOOR HOSPITALS PRICE TARGET TO 1306 (1266) PENCE - 'BUY'
----------
GOLDMAN SACHS RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 2410 (2120) PENCE - 'NEUTRAL'
----------
NOMURA CUTS AMEC PRICE TARGET TO 1000 (1220) PENCE - 'BUY'
----------
NOMURA RAISES HUNTING TO 'NEUTRAL' ('REDUCE') - TARGET 390 (570) PENCE
----------
NOMURA CUTS JOHN WOOD PRICE TARGET TO 435 (520) PENCE - 'REDUCE'
----------
PANMURE INITIATES SENIOR PLC WITH 'BUY' - TARGET 417 PENCE
----------
NUMIS CUTS ZOOPLA PROPERTY PRICE TARGET TO 215 (235) PENCE - 'ADD'
----------
MAIN MARKET AND AIM
----------
UBS CUTS DARTY PRICE TARGET TO 90 (95) PENCE - 'BUY'
----------
BERENBERG CUTS ASOS PRICE TARGET TO 3500 (3785) PENCE - 'BUY'
----------
NOMURA CUTS LAMPRELL PRICE TARGET TO 125 (200) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.